CarthroniX
Lancaster
About CarthroniX
CarthroniX develops small-molecule-based therapies for cartilage diseases, including arthritis. They are able to preserve, repair, and regenerate cartilage in joints and simultaneously suppress inflammation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.2M
- Last round: Convertible Note (Apr 2022)
- Website: carthronix.com
- Phone: +1-949-885-1907
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/carthronix-42776 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.